| Systemic inflammation in decompensated cirrhosis: characterization and role in acute‐on‐chronic liver failure J Clària, RE Stauber, MJ Coenraad, R Moreau, R Jalan, M Pavesi, ... Hepatology 64 (4), 1249-1264, 2016 | 762 | 2016 |
| Clinical course of acute‐on‐chronic liver failure syndrome and effects on prognosis T Gustot, J Fernandez, E Garcia, F Morando, P Caraceni, C Alessandria, ... Hepatology 62 (1), 243-252, 2015 | 704 | 2015 |
| Ribavirin for chronic hepatitis E virus infection in transplant recipients N Kamar, J Izopet, S Tripon, M Bismuth, S Hillaire, J Dumortier, ... New England Journal of Medicine 370 (12), 1111-1120, 2014 | 521 | 2014 |
| Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors E De Martin, JM Michot, B Papouin, S Champiat, C Mateus, O Lambotte, ... Journal of hepatology 68 (6), 1181-1190, 2018 | 454 | 2018 |
| Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3 F Artru, A Louvet, I Ruiz, E Levesque, J Labreuche, J Ursic-Bedoya, ... Journal of hepatology 67 (4), 708-715, 2017 | 362 | 2017 |
| Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: a European study LS Belli, M Berenguer, PA Cortesi, M Strazzabosco, SR Rockenschaub, ... Journal of hepatology 65 (3), 524-531, 2016 | 337 | 2016 |
| Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation X Forns, M Charlton, J Denning, JG McHutchison, WT Symonds, ... Hepatology 61 (5), 1485-1494, 2015 | 257 | 2015 |
| Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience A Coilly, B Roche, J Dumortier, V Leroy, D Botta-Fridlund, S Radenne, ... Journal of hepatology 60 (1), 78-86, 2014 | 232 | 2014 |
| Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium E d'Aldebert, MJBB Mve, M Mergey, D Wendum, D Firrincieli, A Coilly, ... Gastroenterology 136 (4), 1435-1443, 2009 | 229 | 2009 |
| Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients F Chiappini, A Coilly, H Kadar, P Gual, A Tran, C Desterke, D Samuel, ... Scientific reports 7 (1), 46658, 2017 | 213 | 2017 |
| A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation N Golse, PO Bucur, O Ciacio, G Pittau, A Sa Cunha, R Adam, D Castaing, ... Liver Transplantation 23 (2), 143-154, 2017 | 190 | 2017 |
| Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19: results from the ELITA/ELTR multi-center European study LS Belli, C Fondevila, PA Cortesi, S Conti, V Karam, R Adam, A Coilly, ... Gastroenterology 160 (4), 1151-1163. e3, 2021 | 154 | 2021 |
| The impact of treatment of hepatitis C with DAA s on the occurrence of HCC B Roche, A Coilly, JC Duclos‐Vallee, D Samuel Liver international 38, 139-145, 2018 | 151 | 2018 |
| Efficacy of sofosbuvir and daclatasvir in patients with fibrosing cholestatic hepatitis C after liver transplantation V Leroy, J Dumortier, A Coilly, M Sebagh, C Fougerou-Leurent, ... Clinical Gastroenterology and Hepatology 13 (11), 1993-2001. e2, 2015 | 134 | 2015 |
| Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS) LS Belli, C Duvoux, T Artzner, W Bernal, S Conti, PA Cortesi, SC Sacleux, ... Journal of hepatology 75 (3), 610-622, 2021 | 133 | 2021 |
| Assessment of malnutrition, sarcopenia and frailty in patients with cirrhosis: which tools should we use in clinical practice? B Buchard, Y Boirie, L Cassagnes, G Lamblin, A Coilly, A Abergel Nutrients 12 (1), 186, 2020 | 126 | 2020 |
| Portopulmonary hypertension in the current era of pulmonary hypertension management L Savale, M Guimas, N Ebstein, M Fertin, M Jevnikar, S Renard, ... Journal of Hepatology 73 (1), 130-139, 2020 | 121 | 2020 |
| Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation D Samuel, A Coilly BMC medicine 16, 1-5, 2018 | 114 | 2018 |
| Ribavirin for hepatitis E virus infection after organ transplantation: a large European retrospective multicenter study N Kamar, F Abravanel, P Behrendt, J Hofmann, GP Pageaux, C Barbet, ... Clinical Infectious Diseases 71 (5), 1204-1211, 2020 | 106 | 2020 |
| Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence–The ANRS CUPILT study A Coilly, C Fougerou-Leurent, V De Ledinghen, P Houssel-Debry, ... Journal of hepatology 65 (4), 711-718, 2016 | 101 | 2016 |
